글로벌 자동 인슐린 투여 장치 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 자동 인슐린 투여 장치 시장

자동 인슐린 투여 장치 시장은 2021년부터 2028년까지의 예측 기간 동안 5%의 시장 성장을 목격할 것으로 예상됩니다. 자동 인슐린 투여 장치 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 당뇨병과 그 합병증에 대한 인식 프로그램과 캠페인의 증가는 자동 인슐린 투여 장치 시장의 성장을 가속화하고 있습니다.

자동 인슐린 투여 장치는 하이브리드 폐쇄 루프라고도 합니다. 혈액 내 포도당 수치를 유지하고 저혈당 사례를 줄이는 데 사용됩니다.

예측 기간 동안 자동 인슐린 투여 장치 시장 성장을 촉진할 것으로 예상되는 주요 요인은 전 세계적으로 당뇨병 유병률이 증가하고 있다는 것 입니다. 또한 제품 출시에 대한 발명은 자동 인슐린 투여 장치 시장 성장을 더욱 촉진할 것으로 예상됩니다. 또한 인슐린 투여 장치의 기술 개발은 자동 인슐린 투여 장치 시장 성장을 완화할 것으로 예상됩니다. 반면, 대체 약물 투여 프로세스로서의 경구 인슐린은 타임라인 기간 동안 자동 인슐린 투여 장치 시장 성장을 더욱 방해할 것으로 예상됩니다.

또한 선진국에서 인식 프로그램과 환불 시나리오가 증가함에 따라 향후 몇 년 동안 자동 인슐린 투여 장치 시장이 성장할 수 있는 잠재적 기회가 더욱 제공될 것입니다. 그러나 펜 니들과 주입 세트의 재사용은 가까운 미래에 자동 인슐린 투여 장치 시장 성장에 더욱 큰 도전이 될 수 있습니다.

This automated insulin delivery devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the healthcare analytical testing services market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you take an informed market decision to achieve market growth. 

Automated Insulin Delivery Devices Market Scope and Market Size

The automated insulin delivery devices market is segmented on the basis of type and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications. 

• On the basis of type, the automated insulin delivery devices market is segmented into pens, insulin pumps, pen needles, insulin syringes, and others.
• On the basis of end-users, the automated insulin delivery devices market is segmented into home care, hospitals, and clinics.

Automated Insulin Delivery Devices Market Country Level Analysis

The automated insulin delivery devices market is analysed, and market size insights and trends are provided by country, type, and end-user as referenced above.      

The countries covered in the automated insulin delivery devices market report are the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina and rest of South America as part of South America.

North America dominates the automated insulin delivery devices market due to the rise in the diabetic population. Moreover, the availability of technologically advanced devices will further boost the growth of the automated insulin delivery devices market in the region during the forecast period. Asia-Pacific is projected to observe a significant amount of growth in the automated insulin delivery devices market due to the rise in the population. Moreover, the growth of the geriatric and diabetic population is further anticipated to propel the growth of the automated insulin delivery devices market in the region in the coming years.

The country section of the automated insulin delivery devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import-export analysis, price trend analysis, cost of raw materials, downstream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The automated insulin delivery devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kinds of products for automated insulin delivery devices market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the automated insulin delivery devices market. The data is available for the historic period 2010-2019.

Competitive Landscape and Automated Insulin Delivery Devices Market Share Analysis

The automated insulin delivery devices market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the automated insulin delivery devices market.

자동 인슐린 투여 장치 시장 보고서에서 다루는 주요 업체는 Novo Nordisk A/S, Sanofi, Lilly, Biocon, Ypsomed, Wockhardt, Digital Medics, Abbott, Companion Medical, F. Hoffmann-La Roche, Ltd., BD, Animas LLC, Medtronic., Tandem Diabetes Care, Inc, Diabetes Care, BIGFOOT BIOMEDICAL, INC., DreaMed Diabetes, Ltd, WTWH Media LLC 등 국내 및 글로벌 업체입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-47752